Jefferies Downgrades AcelRx Pharmaceuticals After FDA Requests Additional Clinical Trial For Lead Drug Zalviso
March 10, 2015 at 11:55 AM EDT
Shares of AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) were down substantially on Tuesday after its earnings call on Monday. Although ...